Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1420 ARTÍCULOS , VIENDO DEL 1 AL 15

Neuropsychiatric symptoms across the revised Alzheimer's disease clinical staging framework: A review of current evidence and implications

Sankhe K, Vellone D, Guan DX, Creese B, Ismail Z, Kumar S, Lanctôt KL, Mortby ME, de Oliveira FF, Sinclair L, Gatchel J, Munro CE.

Alzheimers Dement (Amst). 2026 Nov 2;18(4):e70510. doi: 10.1002/dad2.70510. eCollection 2026 Oct-Dec.

Cultural Adaptation and Psychometric Properties of the Caregiving Ambivalence Scale for Brazilian Family Caregivers

Ferreira HG, Losada-Baltar A, Márquez-González M, Vieira da Silva Falcão D, Cavalcante da Silva IK, Dos Santos Oliveira Marques Dantas J.

Clin Gerontol. 2026 Oct-Dec;49(5):1227-1238. doi: 10.1080/07317115.2026.2689613. Epub 2026 Jun 17.

A review of dextromethorphan and bupropion (Auvelity™) for the treatment of agitation in Alzheimer's disease

Tampi RR, Murphy K, Golden J, Schuster H, Conyers R.

Drugs Context. 2026 Oct 7;15:2026-6-4. doi: 10.7573/dic.2026-6-4. eCollection 2026.

The orexinergic-endocannabinoid interface: mechanistic and therapeutic perspectives in Alzheimer's disease, anxiety, and visceral pain

Bodke S, Shelke P, Bhatt LK.

Neuropeptides. 2026 Oct 26;120:102665. doi: 10.1016/j.npep.2026.102665. Online ahead of print.

Non-pharmacological interventions for sleep improvement in Alzheimer's disease: A systematic review and meta-analysis

Zhang Q, Zhou Q, Yang M, Zou S, Li Y, Wang Z.

J Alzheimers Dis. 2026 Oct;113(4):1555-1569. doi: 10.1177/13872877261480066. Epub 2026 Sep 1.

From pathogenesis to non-medical therapy: A review of exploring sensory and multi-sensory stimulation as a non-invasive treatment approach for Alzheimer's disease

Zhu Y, Jafari Z, Kolb BE, Mohajerani MH.

Neurosci Biobehav Rev. 2026 Dec;191:107004. doi: 10.1016/j.neubiorev.2026.107004. Epub 2026 Oct 7.

How can physicians empathetically deliver a diagnosis that reflects the evolving landscape of Alzheimer's disease care: A scoping review

Duhan A, Lu WH, Post S.

J Alzheimers Dis Rep. 2026 Oct 8;10:25424823261476636. doi: 10.1177/25424823261476636. eCollection 2026 Jan-Dec.

Resilience to mid-to-late-life depression as a risk factor for Alzheimer's disease: Physiological factors and the role of neuroimaging

Chu TDX, Hui LM, Khatri N, Jean Chen J.

Neurobiol Aging. 2026 Oct;166:1-13. doi: 10.1016/j.neurobiolaging.2026.05.004. Epub 2026 May 6.

Mapping the nature, type, and association network of safety incidents among individuals with cognitive impairment in China: a large-scale multicenter cross-sectional study

Zhou Y, Peng G, Liao Z, Liu H, Liu J, Liao W, Qu Q, Shi J, Geng J, Zhi N, Cao W, Song Y, Zhang Y, Wang X, Wang L, Zhu Y, Zhou Y, Wang H, Sun Y, Ren R, Xie H, Wang G; representing ADC.

J Prev Alzheimers Dis. 2026 Oct;13(8):100606. doi: 10.1016/j.tjpad.2026.100606. Epub 2026 May 29.

Longitudinal Impact of Agitation and Aggression Symptoms on Societal Costs in Alzheimer's Disease: A Focus on Informal Care and Socioeconomic Disparities

Costa N, Marcélo Fleuret C, Gombault E, Soto Martin M, De Mauleon A.

Int J Geriatr Psychiatry. 2026 Oct;41(10):e70257. doi: 10.1002/gps.70257.

Biomarker profiles in late-life depression and Alzheimer's disease across and beyond the A/T/N framework: A scoping review

Zhu Y, Damera N, Singh RK, Bekena S, Kelble L, McGuire K, Hu Y, Mersiehazen E, Vijay G, Nazif A, Kolady R, Xiang L, Liu X, Flores S, Dombrowski K, Pal S, Hardi A, Taylor K, Trani JF, Ances BM, Lenze EJ, Vemuri P, Jack CR Jr, Petersen RC, Babulal GM.

Alzheimers Dement. 2026 Oct;22(10):e71739. doi: 10.1002/alz.71739.

Andrographolide: Mechanisms and Therapeutic Potential in Alzheimer's and Parkinson's Disease

Ríos-Gallardo A, Herrera-Ramirez D, Bastias-Candia S, Inestrosa NC.

Molecules. 2026 Sep 8;31(18):3139. doi: 10.3390/molecules31183139.

Aluminum chloride in Alzheimer's disease: A dual focus on molecular mechanisms and rat experimental models

Khattab NA, El Kadeem A, Goda AE, El-Mahdy NA, El-Shitany N.

Exp Neurol. 2026 Sep;403:115814. doi: 10.1016/j.expneurol.2026.115814. Epub 2026 May 8.

Analytical and Clinical Validity of a High-Throughput, Fully Automated Immunoassay for Plasma Neurofilament Light Chain

Unruh D, Todtleben J, Johnson K, Schlichtmann B, Szabo M, Holland M, Carlson C, Hinson J, Levin S.

J Appl Lab Med. 2026 Sep 3;11(5):1161-1173. doi: 10.1093/jalm/jfag052.

A GPCR atlas across human microglial states in Alzheimer's disease: Insights from snRNA-seq and hiPSC models

Zhang B, Ran Z, Li XY, Wei ZH, Wang DM, Lu MH.

Exp Neurol. 2026 Sep;403:115845. doi: 10.1016/j.expneurol.2026.115845. Epub 2026 May 21.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias